Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1
Myotonic dystrophy type 1 (DM1) is associated with aberrant transcript splicing. Here, the authors develop a transgenic mouse model expressing a bi-chromatic reporter system that allows non-invasive monitoring of splicing of a transcript altered in DM1 in vivo, and show that it allows for evaluation...
Guardado en:
Autores principales: | Ningyan Hu, Layal Antoury, Timothy M. Baran, Soumya Mitra, C. Frank Bennett, Frank Rigo, Thomas H. Foster, Thurman M. Wheeler |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b1565fb81d1d487aac6b620c6b16e1b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies
por: Layal Antoury, et al.
Publicado: (2018) -
Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy
por: Marzena Wojciechowska, et al.
Publicado: (2018) -
Epigenetics of Myotonic Dystrophies: A Minireview
por: Virginia Veronica Visconti, et al.
Publicado: (2021) -
Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy
por: Fernande Freyermuth, et al.
Publicado: (2016) -
Cardiac Pathology in Myotonic Dystrophy Type 1
por: Mani S. Mahadevan, et al.
Publicado: (2021)